Trial Profile
A Dose Escalation Study to Investigate the Pharmacokinetics, Tolerability and Safety of Liraglutide After Multiple s.c. Doses in Healthy Chinese Male Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jan 2009 Actual patient number (37) added as reported by ClinicalTrials.gov.
- 13 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.